| 000 | 01870cam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030911.0 | ||
| 008 | 131208s2012 ua do f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.12.02.M.Sc.2012.Mo.E | ||
| 100 | 0 | _aMohammed Sobhy Ahmed Mohammed | |
| 245 | 1 | 0 |
_aEvaluation of immune response to hepatitis B vaccine in Egypt and generation of the corresponding antibodies against the recombinant HBV vaccines / _cMohammed Sobhy Ahmmed Mohammed ; Supervised Mervat Elsayed , Mostafa Kamel Elawady |
| 246 | 1 | 5 | _aتقييم الاستجابة المناعية للقاح فيروس التهاب الكبد الوبائى (ب) فى مصر: و توليد الأجسام المضادة ضد لقاح التهاب الكبد الوبائى -ب |
| 260 |
_aCairo : _bMohammed Sobhy Ahmed Mohammed , _c2012 |
||
| 300 |
_a130 P. : _bcharts , photographs ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Science - Department of Biochemistry | ||
| 520 | _aThe study aimed to evaluate immune responses of hepatitis B vaccine in Egypt. 135 adult vaccinated subject were divided in to three group. Fully vaccinated (112 subjects) who received hepatitis B vaccine at 0, 1 and 6 moths. Partially vaccinated (11 subject) who didn't take full dose of hepatitis B vaccine. Vaccinated with HCV (8 subjects) who have past history of infection with HCV | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aHepatitis B vaccine | |
| 653 | 4 | _aImmune response to hepatitis B | |
| 653 | 4 | _aRisk of infection after vaccination | |
| 700 | 0 |
_aMervat Elsayed , _eSupervisor |
|
| 700 | 0 |
_aMostafa Kamel Elawady , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c44331 _d44331 |
||